US Senators Demand Measures From USPTO to Combat Pharma Patent Thickets
Last week, a bipartisan group of six U.S. senators sent a letter to USPTO asking to take measures in order to combat patent thickets coming from pharmaceutical companies. Republican senators John...
View ArticleCureVac Files Patent Infringement Lawsuit in Germany Against BioNTech
Two weeks ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent infringement alleging that BioNTech’s Covid-19 vaccine infringed its patents related to...
View ArticleThe Benefits and Effects of Hatch- Waxman Act Four Decades Later
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that time, Roche Products Inc. held patent rights for flurazepam...
View ArticlePatexia Insight 148: ANDA Litigation Grows in the First Half of 2022
This morning we released our third annual ANDA Litigation Intelligence Report. The report covers high-level statistics related to Hatch-Waxman litigation including the analysis of the outcomes, most...
View ArticleThe U.S. Supreme Court is About to Ultimately Decide Amgen vs Sanofi Antibody...
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought battle between Amgen and Sanofi in 2021 with the CAFC decision. As a...
View Article